There is much current publicity over the risks to laboratory staff associated with handling specimens from patients infected with human immunodeficiency virus (HIV). Although standard tissue fixation methods inactivate most infectious agents, including HIV, they also render some antigens undetectable by immunocytochemistry and are unsuitable if cryostat sections are necessary.
Betapropiolactone (BPL) inactivates viruses in blood, serum, or plasma and enables them to be handled outside category 3 containment facilities. Some biochemical and haematological variables are affected by treatment with BPL, but far fewer than by heat inactivation or other sterilising procedures.' BPL is relatively non-toxic, and can be safely handled in a fume cabinet but is carcinogenic in rats.
The effect of BPL on unfixed biopsy and necropsy tissues was investigated to establish if viruses were inactivated and if viral and tissue antigens were preserved.
The viral studies were performed on tissues from suckling mice infected with Coxsackie virus. This virus is resistant to routine disinfectants, including 70% alcohol and 5% lysol and unaffected by 1% quarternary ammonium compounds or standard detergents which destroy other viruses including HIV.2
Accepted for publication 18 August 1988 Material and methods Coxsackie virus type B5 was isolated from a human faecal specimen and stored at -70°C. Before inoculation into suckling mice the viability of the virus was confirmed by a single passage in Vero cells, grown in a standard cell culture medium.
A litter of six Balb/c mice, less than 48 hours old, was inoculated with 50 p1 of Coxsackie virus in cell culture fluid both intracerebrally and intraperitoneally. All the mice showed signs of infection after 48 hours, characterised by spastic paralysis. The animals were sacrificed, snap frozen, and stored at -700C.
The animals were thawed, skinned, and divided in half longitudinally. One half of each animal was incubated in phosphate buffered saline (PBS), containing BPL (Sigma Chemical Co) to a final concentration of0 25% (v/v) for one hour at room temperature. The other half was treated similarly, with the omission of the BPL step. After treatment each half was further divided transversely. Serial cryostat sections were cut from one half. The other was finely minced in cell culture medium followed by clarifying centrifugation at 2000 rpm for 10 minutes. The supernatants above were serially diluted in cell culture medium from 10-' to 10 and 200 p1 aliquots inoculated on to Vero cells. The virus titre in the untreated tissue was at least 106 necessary, pfu/ml and in the BPL treated tissue the infectivity was unequivoca reduced, with one exception, by a minimum of 4 logs studied. Ot (table 2). inactivate As judged by intensity of fluorescence, the BPL plasma.6 treatment did not destroy virus antigens or alter their intracellular distribution.
No major differences were evident between the intensities of the precipitates produced or in the histological distribution of the hybridisation.
In all instances the tissue antigens studied remained detectable after exposure to BPL (table 1, figure) . The quality of the demonstration was improved when the sections had been fixed in acetone. The tissue morphology was satisfactory in all experiments and not adversely affected by the duration of the exposure or the concentration of the BPL solution. Blocks of tissue pre-treated with BPL were easily sectioned and presented no technical difficulties. Although we did not test the effect of BPL on all known tissue antigens, those studied usually reflect the antigenicity of other common tissue antigens and it is suggested that few, if any, tissue antigens will be adversely affected by BPL. A similar argument is proposed for viral antigens as those in tissues have, to date, shared common sensitivities to routine fixatives. A possible limitation of the method is the carcinogenicity of BPL. Tumours have occurred in rodents but only at moderate and high doses."8 Similar observations have not been made in man and any risk can be reduced by wearing disposable gloves and restricting the substance to extraction cabinets. The end products of the hydrolysis of BPL produced by plasma and serum are not carcinogenic.
In conclusion, exposure of the tissues to BPL is a safe and effective means of inactivating any common viruses and one that is highly appropriate to tissues from patients harbouring or potentially exposed to HIV. There is no evidence that the antigenicity of any tissue component is adversely affected.
